Where the money goes: researcher using LOWVELO funds to revolutionize treatment for solid tumors
Most people don’t have a positive reaction to seeing blood. But MUSC Hollings Cancer Center researcher Leonardo Ferreira, Ph.D. isn’t most people. “Every time I look at a drop of blood, I see cells screaming to be weaponized against cancer.” Ferreira’s lab hopes to bring CAR-T cell therapy, a game-changing treatment showing success in liquid tumors to solid tumors.
